Back Article

Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, et al. 2014. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research 74(11):2913−21

Siegel RL, Miller KD, Jemal A. 2018. Cancer statistics. CA: A Cancer Journal for Clinicians 68(1):7−30

Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, et al. 2007. National failure to operate on early stage pancreatic cancer. Annals of Surgery 246(2):173−80

Kindler HL. 2018. A glimmer of hope for pancreatic cancer. The New England Journal of Medicine 379(25):2463−64

Zhang L, Sanagapalli S, Stoita A. 2018. Challenges in diagnosis of pancreatic cancer. World Journal of Gastroenterology 24(19):2047−60

Jones RM, Devers KJ, Kuzel AJ, Woolf SH. 2010. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. American Journal of Preventive Medicine 38(5):508−16

White A, Thompson TD, White MC, Sabatino SA, de Moor, et al. 2015. Cancer Screening Test Use - United States. Morbidity and Mortality Weekly Report 66(8):201−6

Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE. 2015. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. The American Journal of Clinical Nutrition 101(3):558−69

Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, et al. 2018. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 155(3):648−60

Baquero F, Nombela C. 2012. The microbiome as a human organ. Clinical Microbiology and Infection 18:2−4

Schmidt TSB, Raes J, Bork P. 2018. The Human Gut Microbiome: From Association to Modulation. Cell 172(6):1198−215

Bhatt AP, Redinbo MR, Bultman SJ. 2017. The role of the microbiome in cancer development and therapy. CA: A Cancer Journal for Clinicians 67(4):326−44

Weinstock GM. 2012. Genomic approaches to studying the human microbiota. Nature 489:250−56

Qin J, Li Y, Cai Z, Li S, Zhu J, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55−60

Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, et al. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. The ISME Journal 5(1):82−91

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027−31

Karpiński TM. 2019. Role of oral microbiota in cancer development. Microorganisms 7(1):20

Mascitti M, Togni L, Troiano G, Caponio VCA, Gissi DB, et al. 2019. Beyond head and neck cancer: the relationship between oral microbiota and tumour development in distant organs. Frontiers in Cellular and Infection Microbiology 9:232

Cani PD, Jordan BF. 2018. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nature Reviews Gastroenterology & Hepatology 15(11):671−82

Ren Z, Li A, Jiang J, Zhou L, Yu Z, et al. 2019. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 68(6):1014−23

Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, et al. 2014. Potential of fecal microbiota for early-stage detection of colorectal cancer. Molecular Systems Biology 10:766

Liang Q, Chiu J, Chen Y, Huang Y, Higashimori A, et al. 2017. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clinical Cancer Research 23(8):2061−70

Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, et al. 2012. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61(4):582−88

Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, et al. 2013. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 62(12):1764−70

Clarridge JE 3rd. 2004. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clinical Microbiology Reviews 17(4):840−62

Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, et al. 2018. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67(1):120−27

Half E, Keren N, Reshef L, Dorfman T, Lachter I, et al. 2019. Fecal microbiome signatures of pancreatic cancer patients. Scientific Reports 9:16801

Lu H, Ren Z, Li A, Li J, Xu S, et al. 2019. Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. Journal of Oral Microbiology 11:1563409

Olson SH, Satagopan J, Xu Y, Ling L, Leong S, et al. 2017. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Cancer Causes Control 28(9):959−69

Ren Z, Jiang J, Xie H, Li A, Lu H, et al. 2017. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget 8(56):95176−91

Torres PJ, Fletcher EM, Gibbons SM, Bouvet M, Doran KS, et al. 2015. Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ 3:e1373

Vogtmann E, Han Y, Caporaso JG, Bokulich N, Mohamadkhani A, et al. 2020. Oral microbial community composition is associated with pancreatic cancer: A case-control study in Iran. Cancer Medicine 9(2):797−806

Half E, Keren N, Dorfman T, Reshef L, Lachter I, et al. 2015. Specific changes in fecal microbiota may differentiate pancreatic cancer patients from healthy individuals. Annals of Oncology 26:iv48

Lin IH, Wu J, Cohen SM, Chen C, et al. 2013. Pilot study of oral microbiome and risk of pancreatic cancer. Proceedings of the 104 ^th Annual Meeting of the American Association for Cancer Research, 6−10 Apr. 2013. Washington, DC, USA: American Association for Cancer Research (AACR). 73 pp. doi: 10.1158/1538-7445.AM2013-1738

Kartal E, Schmidt TSB, Molina-Montes E, Rodríguez-Perales S, Wirbel J, et al. 2022. A faecal microbiota signature with high specificity for pancreatic cancer. Gut 71(7):1359−72

Chen T, Li X, Li G, Liu Y, Huang X, et al. 2023. Alterations of commensal microbiota are associated with pancreatic cancer. The International Journal of Biological Markers 38(2):89−98

Zhao F, Chen A, Wu X, Deng X, Yang J, et al. 2024. Heterogeneous changes in gut and tumor microbiota in patients with pancreatic cancer: insights from clinical evidence. BMC Cancer 24:478

Hashimoto S, Tochio T, Funasaka K, Funahashi K, Hartanto T, et al. 2023. Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result. Scandinavian Journal of Gastroenterology 58(2):193−98

Sono M, Iimori K, Nagao M, Ogawa S, Maruno T, et al. 2024. Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer. Pancreatology 24(7):1031−39

Yang J, Ma Y, Tan Q, Zhou B, Yu D, et al. 2023. Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer. Frontiers in Microbiolog 14:1184869

Cota GF, de Sousa MR, Fereguetti TO, Rabello A. 2013. Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison. PLoS Neglected Tropical Diseases 7(5):e2195

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457:480−84

He Y, Wu W, Zheng HM, Li P, McDonald D, et al. 2018. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine 24(10):1532−35

Grine G, Terrer E, Boualam MA, Aboudharam G, Chaudet H, et al. 2018. Tobacco-smoking-related prevalence of methanogens in the oral fluid microbiota. Scientific Reports 8:9197

Ertz-Archambault N, Keim P, Von Hoff D. 2017. Microbiome and pancreatic cancer: A comprehensive topic review of literature. World Journal of Gastroenterology 23(10):1899−908

Wang Y, Yang G, You L, Yang J, Feng M, et al. 2019. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Molecular Cancer 18:173

Wei MY, Shi S, Liang C, Meng QC, Hua J, et al. 2019. The microbiota and microbiome in pancreatic cancer: more influential than expected. Molecular Cancer 18(1):97

Maisonneuve P, Amar S, Lowenfels AB. 2017. Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis. Annals of Oncology 28(5):985−95

Meurman JH. 2010. Oral microbiota and cancer. Journal of Oral Microbiology 2:5195

Öğrendik M. 2017. Periodontal pathogens in the etiology of pancreatic cancer. Gastrointestinal Tumors 3(3−4):125−27

Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE. 2012. Leptotrichia bacteremia in patients receiving high-dose chemotherapy. Journal of Clinical Microbiology 50(4):1228−32

Cooreman S, Schuermans C, Van Schaeren J, Olive N, Wauters G, et al. 2011. Bacteraemia caused by Leptotrichia trevisanii in a neutropenic patient. Anaerobe 17(1):1−3

Bozkurt SB, Hakki SS, Hakki EE, Durak Y, Kantarci A. 2017. Porphyromonas gingivalis Lipopolysaccharide Induces a Pro-inflammatory Human Gingival Fibroblast Phenotype. Inflammation 40(1):144−53

Leonov GE, Varaeva YR, Livantsova EN, Starodubova AV. 2023. The complicated relationship of short-chain fatty acids and oral microbiome: a narrative review. Biomedicines 11(10):2749

Liu XB, Gao ZY, Sun CT, Wen H, Gao B, et al. 2019. The potential role of P. gingivalis in gastrointestinal cancer: a mini review. Infectious Agents and Cancer 14:23

Lin J, Huang D, Xu H, Zhan F, Tan X. 2022. Macrophages: A communication network linking Porphyromonas gingivalis infection and associated systemic diseases. Frontiers in Immunology 13:952040

Yu J, Feng Q, Wong SH, Zhang D, Liang QY, et al. 2017. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66(1):70−78

Maekawa T, Fukaya R, Takamatsu S, Itoyama S, Fukuoka T, et al. 2018. Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. Biochemical and Biophysical Research Communications 506(4):962−69

Meng Z, Cao M, Zhang Y, Liu Z, Wu S, et al. 2019. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis. BMC Gastroenterology 19:59

Winer LK, Dhar VK, Wima K, Morris MC, Lee TC, et al. 2019. The impact of tumor location on resection and survival for pancreatic ductal adenocarcinoma. The Journal of Surgical Research 239:60−66

Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, et al. 2018. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discovery 8(4):403−16

Bravo-Blas A, Utriainen L, Clay SL, Kästele V, Cerovic V, et al. 2019. Salmonella enterica serovar typhimurium travels to mesenteric lymph nodes both with host cells and autonomously. Journal of Immunology 202(1):260−67

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, et al. 2019. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178(4):795−806.E12

Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, et al. 2017. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357:1156−60

Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, et al. 1993. Pancreatitis and the risk of pancreatic cancer. The New England Journal of Medicine 328(20):1433−37

Jandhyala SM, Madhulika A, Deepika G, Rao GV, Reddy DN, et al. 2017. Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Scientific Reports 7:43640

Leal-Lopes C, Velloso FJ, Campopiano JC, Sogayar MC, Correa RG. 2015. Roles of commensal microbiota in pancreas homeostasis and pancreatic pathologies. Journal of Diabetes Research 2015:284680

Mai CW, Kang YB, Pichika MR. 2013. Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. OncoTargets and Therapy 6:1573−87

Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, et al. 2018. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research 37:319

Perez-Chanona E, Trinchieri G. 2016. The role of microbiota in cancer therapy. Current Opinion in Immunology 39:75−81

Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, et al. 2015. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:1079−84

Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, et al. 2018. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359:97−103

Sethi V, Kurtom S, Tarique M, Lavania S, Malchiodi Z, et al. 2018. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response. Gastroenterology 155:33−37.E6

Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, et al. 2012. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. The Journal of Experimental Medicine 209(9):1671−87

Ochi A, Graffeo CS, Zambirinis CP, Rehman A, Hackman M, et al. 2012. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. The Journal of Clinical Investigation 122(11):4118−29

Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, et al. 2014. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discovery 4(12):1387−97

Sebastián C, Mostoslavsky R. 2014. Untangling the fiber yarn: butyrate feeds Warburg to suppress colorectal cancer. Cancer Discovery 4(12):1368−70

Armstrong H, Bording-Jorgensen M, Dijk S, Wine E. 2018. The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it. Cancers 10(3):83

Marshall BJ, Warren JR. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet 323:1311−15

Xiao M, Wang Y, Gao Y. 2013. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS ONE 8(9):e75559

Schulte A, Pandeya N, Fawcett J, Fritschi L, Risch HA, et al. 2015. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control 26(7):1027−35

Jin Y, Gao H, Chen H, Wang J, Chen M, et al. 2013. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues. Cancer Letters 335(2):447−54

Fiorino S, Visani M, Acquaviva G, Fornelli A, Masetti M, et al. 2016. Search for HBV and HCV Genome in Cancer Cells of Pancreatic Tumors. Pancreas 45(1):e12−e14

Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, et al. 2019. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574(7777):264−67

Rishi A, Goggins M, Wood LD, Hruban RH. 2015. Pathological and molecular evaluation of pancreatic neoplasms. Seminars in Oncology 42(1):28−39